Tuesday, June 21, 2022 9:55:22 AM
JadiCell for COPD (IND #28508)
JadiCell for Chronic Traumatic Encephalopathy (IND #27377)
JadiCell for Idiopathic Pulmonary Fibrosis (Late Preclinical)
StemVacs Dendritic Cells for Breast Cancer (IND #28508)
StemVacs-V iPSC Derived Tumor Endothelial Targeting Vaccine (Late Preclinical)
Bio next week Post by TimGDixon » Fri Jun 10, 2022 6:18 pm
Most of you know next week BIO happens and Venvalo Group will be there to present the following opportunities on our behalf in One-on-One meetings for out-licensing and collaborative/partnerships. There will be no recordings as these are pre-arranged one on one meetings that are rapid so you can get maximum exposure. This is where pharma biopharma shops and something like 3,682 companies will be present.
JadiCell for COVID-19 (Phase III ongoing #19757)
JadiCell for COPD (IND #28508)
JadiCell for Chronic Traumatic Encephalopathy (IND #27377)
JadiCell for Idiopathic Pulmonary Fibrosis (Late Preclinical)
StemVacs Dendritic Cells for Breast Cancer (IND #28508)
StemVacs-V iPSC Derived Tumor Endothelial Targeting Vaccine (Late Preclinical)
https://forum.therapeuticsolutionsint.com/viewtopic.php?p=4624&hilit=Venvalo+Group#p4624
Recent TSOI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 10:03:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:15:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:12:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 10:25:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:16:15 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/08/2024 05:15:25 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 11:34:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 08:42:55 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/17/2024 11:15:01 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/04/2024 09:03:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 07:44:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:39:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:17:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:13:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 06:50:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 05:44:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:24:52 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 11:10:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:29:10 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM